In utero exposure to endocrine-disrupting chemicals, maternal factors and alterations in the epigenetic landscape underlying later-life health effects

Environ Toxicol Pharmacol. 2022 Jan:89:103779. doi: 10.1016/j.etap.2021.103779. Epub 2021 Nov 27.

Abstract

Widespread persistence of endocrine-disrupting chemicals (EDCs) in the environment has mandated the need to study their potential effects on an individual's long-term health after both acute and chronic exposure periods. In this review article a particular focus is given on in utero exposure to EDCs in rodent models which resulted in altered epigenetic programming and transgenerational effects in the offspring causing disrupted reproductive and metabolic phenotypes. The literature to date establishes the impact of transgenerational effects of EDCs potentially associated with epigenetic mediated mechanisms. Therefore, this review aims to provide a comprehensive overview of epigenetic programming and it's regulation in mammals, primarily focusing on the epigenetic plasticity and susceptibility to exogenous hormone active chemicals during the early developmental period. Further, we have also in depth discussed the epigenetic alterations associated with the exposure to selected EDCs such as Bisphenol A (BPA), di-2-ethylhexyl phthalate (DEHP) and vinclozlin upon in utero exposure especially in rodent models.

Keywords: Endocrine disrupting chemicals; Epigenetic mechanism; Human health; Metabolic outcomes; Reproduction; in utero exposure.

Publication types

  • Review

MeSH terms

  • Animals
  • Endocrine Disruptors / toxicity*
  • Epigenesis, Genetic*
  • Female
  • Mammals
  • Maternal Inheritance
  • Pregnancy
  • Prenatal Exposure Delayed Effects*

Substances

  • Endocrine Disruptors